Status:
UNKNOWN
Study of Kidney Circulating Cell-free DNA in Patients With Acute Kidney Failure
Lead Sponsor:
CGenetix
Collaborating Sponsors:
Centre Hospitalier Sud Francilien
Conditions:
Kidney Failure, Acute
Eligibility:
All Genders
18-99 years
Brief Summary
The amount of total circulating DNA has been shown to increase in patients with acute renal failure. Nevertheless, it is currently not currently possible to prove the renal origin of this circulating ...
Detailed Description
When the patient arrives, a first stage of checking the inclusion/non-inclusion criteria will be respected. Patients who do not meet the eligibility criteria will not be sampled (pre-screening stage)....
Eligibility Criteria
Inclusion
- Age \> 18 years old
- Admitted for suspicion of acute renal injury (organic) and/or with an indication for renal biopsy (PBR)
- Patients hospitalized with functional acute renal failure (negative control and inclusion limited to n = 30 maximum)
Exclusion
- Patients \< 18 years old
- Patients with cognitive and mental disorders making them unable to express their non-objection to participation in the study
- Patients with obstructive renal failure
- Patients with chronic renal failure
- Patients who expressed their refusal to participate in the study
Key Trial Info
Start Date :
September 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 10 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05399420
Start Date
September 10 2022
End Date
January 10 2023
Last Update
June 1 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.